Exelixis Inc. buy Guggenheim
Start price
30.10.24
/
50%
€29.87
Target price
30.10.25
€30.37
Performance (%)
10.91%
End price
31.10.25
€33.13
Summary
This prediction ended on 31.10.25 with a price of €33.13. The prediction had a final performance of 10.91%. Guggenheim has a follow-up prediction for Exelixis Inc. where he still thinks Exelixis Inc. is a Buy. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Exelixis Inc. | -0.963% | -0.963% | 15.941% |
| iShares Core DAX® | 0.444% | 3.030% | 12.677% |
| iShares Nasdaq 100 | 3.819% | 4.073% | 33.152% |
| iShares Nikkei 225® | 1.148% | 6.904% | 45.488% |
| iShares S&P 500 | 2.371% | 2.677% | 25.689% |
Comments by Guggenheim for this prediction
In the thread Exelixis Inc. diskutieren
Exelixis, Inc. (NASDAQ: EXEL) had its price target raised by analysts at Guggenheim from $32.00 to $33.00. They now have a "buy" rating on the stock.
Ratings data for EXEL provided by MarketBeat
In the thread Trading Exelixis Inc.
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten